Study to Evaluate Amyloid in Blood and Imaging Related to Dementia

CompletedOBSERVATIONAL

Enrollment

1,122

Participants

Timeline

Start Date

April 9, 2019

Primary Completion Date

January 29, 2024

Study Completion Date

January 31, 2024

Conditions

Alzheimer DiseaseAlzheimer Dementia

Interventions

OTHER

Blood collection, PiB PET/MRI, and cognitive testing

Blood and imaging results will be analyzed for amyloid beta. Cognitive testing will be performed to determine clinical and cognitive status.

Trial Locations (1)

Washington University School of Medicine, St Louis

All Listed Sponsors

lead

Washington University School of Medicine

OTHER

NCT03899844 - Study to Evaluate Amyloid in Blood and Imaging Related to Dementia | Biotech Hunter | Biotech Hunter